Literature DB >> 15011867

Long-term results of central inferior (S4a+S5) hepatic subsegmentectomy and pancreatoduodenectomy combined with extended lymphadenectomy for gallbladder carcinoma with subserous or mild liver invasion (pT2-3) and nodal involvement: a preliminary report.

Ryoko Sasaki1, Yuichiro Takeda, Koichi Hoshikawa, Masahiro Takahashi, Osamu Funato, Hiroyuki Nitta, Masahiko Murakami, Hidenobu Kawamura, Takayuki Suto, Yasunori Yaegashi, Senji Kanno, Kazuyoshi Saito.   

Abstract

BACKGROUND/AIMS: Gallbladder carcinoma, especially advanced cancer that has invaded the subserosal or deeper layers, has a poor prognosis. Recently, radical operations combining resection of the liver and pancreas with extended lymph node dissection have been introduced to improve the prognosis of advanced gallbladder carcinoma. We have introduced central inferior (Couinaud's subsegments 4a and 5; S4a+S5) hepatic subsegmentectomy and pancreatoduodenectomy combined with extended lymphadenectomy for gallbladder carcinoma demonstrating subserous or mild liver invasion (pathological tumor stage pT2-3) and nodal involvement.
METHODOLOGY: Morbidity, mortality, clinicopathological features, and long-term outcome were analyzed retrospectively for seven consecutive patients who underwent this radical operation.
RESULTS: The postoperative morbidity rate was 57.1% and there was no surgical mortality. All patients had lymph node involvement: two had pN1 disease and five had pN2 disease. All patients underwent curative resection. Only one patient developed gallbladder carcinoma recurrence after resection and it involved the paraaortic lymph nodes. Five patients, three of whom displayed pN2 disease, survived longer than 5 years postoperatively with no evidence of disease.
CONCLUSIONS: S4a+S5 hepatic subsegmentectomy and pancreatoduodenectomy combined with extended lymphadenectomy improve the long-term survival of gallbladder carcinoma with pT2-3 and nodal involvement. The presence of pN2 disease is not a contraindication for surgery. Further study is necessary to evaluate the usefulness of this radical procedure, especially as a standard operation.

Entities:  

Mesh:

Year:  2004        PMID: 15011867

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Relevance of residual disease after liver resection for incidental gallbladder cancer.

Authors:  Javier C Lendoire; Luis Gil; Fernando Duek; Carlos Quarin; Verónica Garay; Gabriel Raffin; Marcelo Rivaldi; Oks Alejandra; Oscar Imventarza
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

2.  Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.

Authors:  Li-Ning Xu; Sheng-Quan Zou; Jian-Ming Wang
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 3.  Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it.

Authors:  Ketao Jin; Huanrong Lan; Tieming Zhu; Kuifeng He; Lisong Teng
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

4.  Prognostic significance of the number of positive lymph nodes in gallbladder cancer.

Authors:  Itaru Endo; Hiroshi Shimada; Mikiko Tanabe; Yoshiro Fujii; Kazuhisa Takeda; Daisuke Morioka; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

5.  Impact of the number of examined lymph nodes on outcomes in patients with lymph node-negative gallbladder carcinoma.

Authors:  Dong-Xu Fan; Rong-Wei Xu; Yong-Cheng Li; Bing-Qing Zhao; Ming-Yu Sun
Journal:  World J Gastroenterol       Date:  2018-07-14       Impact factor: 5.742

6.  Robotic fluorescence-guided anatomical segment IVb and V liver resection with radical lymphadenectomy for gall bladder cancer.

Authors:  Raja Kalayarasan; Sankar Narayanan; Mathews James
Journal:  J Minim Access Surg       Date:  2022 Jul-Sep       Impact factor: 1.018

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.